A global collective program to make targeted medicine an accessible reality in oncology and beyond. #PrecisionMedicine #PersonalizedMedicine
Joined October 2020
- Tweets712
- Following588
- Followers1.7K
- Likes926
From Testing to Targeted Treatments (FT3) retweeted
🔵🫁 El proyecto SABIOMARES, de la que forman parte @AEACaP y @FundacionMQI en el marco de @FT3Program, evidencia la necesidad de agilizar el acceso de personas con cáncer a pruebas de biomarcadores en #Andalucía, prioridad de pacientes y profesionales
ℹ️bit.ly/AEACaP-sabiomares-acc…
From Testing to Targeted Treatments (FT3) retweeted
People-centred care transforms cancer treatment, yet access remains uneven. This #WorldCancerDay, experts stress the power of listening to those affected.
🔗 bit.ly/4hxFOAB
#UnitedByUnique
From Testing to Targeted Treatments (FT3) retweeted
Join Nicole Sheahan (President, Global Colon Cancer Association) and Francisco Freyria (General Director, @FUTEJE , member of GCCA) on January 21 (16:00 CET / 10:00 ET) for @FT3Program Value of Precision Medicine Access & Advocacy Workshop.
register: lnkd.in/dC5ftAaQ
From Testing to Targeted Treatments (FT3) retweeted
¿Te perdiste el seminario MEDICINA DE PRECISIÓN EN CÁNCER DE PULMÓN?
⏺️¡Lo tenemos grabado para ti! Hablamos de biomarcadores, diagnóstico molecular,nuevos enfoques de tratamiento y mucho +
Iniciativa de @AEACaP y @FundacionMQI en el marco de @FT3Program
youtube.com/watch?v=sOVUTQ9n…
From Testing to Targeted Treatments (FT3) retweeted
🔵@Ivana_Sullivan señala que en enfermedad avanzada se necesita todo el estudio molecular e invertir tiempo, "sobre todo al inicio", en la búsqueda de biomarcadores para determinar el mejor tratamiento
#SABIOMARES @FT3Program @FundacionMQI @AEACaP
📺youtube.com/live/Y7P2pZAJPew…
From Testing to Targeted Treatments (FT3) retweeted
🔵🫁Desde @AEACaP queremos agradecer a
🔹 @SansanoValero, patóloga molecular @SEAP_IAP
🔹@Ivana_Sullivan, oncóloga médica @gecp_org
haber compartido sus conocimientos sobre la medicina de precisión
➡️ También dar las gracias a @FundacionMQI y a @FT3Program por hacerlo posible
From Testing to Targeted Treatments (FT3) retweeted
Co-creation is happening live at #PEOF by @eupatientsforum, @PFMDwithPatient, @eupatients!
@FT3Program session attendees are testing 2 modules from a co-created #advocacy roadmap and working to improve them! Amazing atmosphere 😍⬇️
@BahijaGouimi, @NABedlington, @LidewijVat, @SusanlMcClure,Vincent Raske.
#personalizedhealthcare
From Testing to Targeted Treatments (FT3) retweeted
Based on identified needs, the @FT3Program community is developing a modular #advocacy roadmap to address these critical challenges faced by advocates. During today's co-creation session, we'll work together to contribute to the readiness of parts of this advocacy roadmap. @BornengoSilvia starts this session with @NicoleMSheahan, @BahijaGouimi , Dr Stuart Faulkner, and Ivica Belina.
From Testing to Targeted Treatments (FT3) retweeted
FT3 Board meeting.
Just met him. Barry Stein!
Metastatic CRC (liver/ lungs) in 1995. Surgery & hepatic arterial infusion.
Amazing; it’s 2024 and he is here looking great & making a difference for others
👉Turning a diagnosis into hope for others. healthing.ca/diseases-and-co…
From Testing to Targeted Treatments (FT3) retweeted
There is still time to participate in this global survey on biomarker testing experiences for patients/caregivers with a #NSCLC Dx in the past 5 years. Available in 5 languages.
WE ARE STILL LOOKING FOR PARTICIPANTS
Help #lungcancer patients become better informed about biomarker testing
Access this survey and you may help patients get the support they require
Let's empower and educate 👉ow.ly/pUXs50R27Nb
@LUNGevity, @LungCancerEu, @IASLC
From Testing to Targeted Treatments (FT3) retweeted
.@IASLC @LUNGevity @LungCancerEu and @COR2ED are partnering on a survey to understand the biomarker testing experience of patients (or their caregivers) diagnosed with #NSCLC in the past five years. @FT3Program @AEACaP @FundacionMQI
From Testing to Targeted Treatments (FT3) retweeted
We would like to understand patients' experience with #biomarker testing around the world. If you (or your loved one) has been diagnosed with #NSCLC in the past 5 years, our survey is available in 5 languages and takes 15 min or less to complete! #LCSM
Want to improve support for patients with #LungCancer?
This survey assesses patients and caregiver's understanding of biomarker testing
Share with your patients to learn how to assist them
@LUNGevity, @LungCancerEu, @IASLC endorsed
ow.ly/Gz8w50QyhAB
With @ChristianRolfo
From Testing to Targeted Treatments (FT3) retweeted
Dr. @VicMorenoGarcia highlights global #inequities in access to drugs for #TRK fusion cancer. In Spain, they are only available through #clinicaltrials. How do we improve access to #precisionmedicine for all around the world who stand to benefit? @NTRKers Patient Summit
From Testing to Targeted Treatments (FT3) retweeted
Becky talks about the important role #BiomarkerTesting plays when it comes to being diagnosed with the ALK+ #lungcancer mutation.
#TogetherWeCan further ALK+ research
#LCAM #LungCancerAwarenessMonth #ALKPositive #ALK #ALKCancerResearch #ResearchSavesLives #MoreResearchMoreLife – at London, England
From Testing to Targeted Treatments (FT3) retweeted
Honoured to participate in ‘Shaping the Future of Personalised Healthcare for Cancer Patients’ @myESMO it is clear that the patient voice can drive change in this field! @BenWestphalen @LindaMileshkin @VivekSubbiah @TumorOnbekend #alwinkramer #vivekmuthu #davidthomas @Roche
From Testing to Targeted Treatments (FT3) retweeted
Helena Harnik from @FT3Program explains the experience of #collaborating with #patients taking an ecosystem approach, to improve access to Personalised Medicine #treatments.
#PM #PersonalisedMedicine #patientengagement #collaboration
From Testing to Targeted Treatments (FT3) retweeted
Thanks to #BiomarkerTesting, Amy, diagnosed w ALK+ #lungcancer age 20, was put on a targeted therapy.
Today she does many of the things she loves - travelling, seeing friends & working!💖
Amy’s experience shows why #BiomarkersMatter
📺youtu.be/Ef3gk1JQZ0E
#GetTested #LCSM
From Testing to Targeted Treatments (FT3) retweeted
Worth watching: short interview between @OncBrothers & Dr @NarjustFlorezMD. Dr Flórez reminds us of the importance of #BiomarkerTesting even in early stage #lungcancer. Particularly love questions Dr Flórez asks of new patients -from social assessments & how are you doing.
#LCSM – at Kensington, London
Thankfully, the landscape of NSCLC is quickly changing = more💊options.
To keep our generalists up to date, in Series 1, w/@NarjustFlorezMD @CharuAggarwalMD + @JackWestMD we🗣️the management of adv NSCLC mEGFR.
#lcsm #MedTwitter #OncEd #MedEd #OncTwitter @EGFRResisters #CME
From Testing to Targeted Treatments (FT3) retweeted
📖 Dive into the CML Story by Anne! worldcmlday.org/2023/09/19/a… 📚 Don't keep your CML journey to yourself – share your story and let your voice be heard! 💬 #WCMLD23 #CureCML
From Testing to Targeted Treatments (FT3) retweeted
On #WorldCMLDay, we focus on awareness, equitable access, & support for those affected by CML. To support this #EHA advocates for affordable & equal access to innovative therapies, personalized medicine, & more.
Read our position papers: eha.fyi/access
#WCMLD23 #CureCML
